c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival.

Background/aim: Data on the clinicopathological features and prognostic impact of c-N-Methyl-N'-nitro-N-nitroso-guanidine HOS Transforming gene (c-MET) and hepatocyte growth factor (HGF) in hepatocellular carcinoma (HCC) are inconsistent. We assessed c-MET and HGF expression in 49 patients with early-stage HCC and correlated the results with disease characteristics and survival.

Materials And Methods: Expression of c-MET and HGF mRNA in tumor (T) and non-tumor (NT) tissues was assessed.